These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 38769391

  • 1. Using blood routine indicators to establish a machine learning model for predicting liver fibrosis in patients with Schistosoma japonicum.
    Liu Y, Xie S, Zhou J, Cai Y, Zhang P, Li J, Ming Y.
    Sci Rep; 2024 May 20; 14(1):11485. PubMed ID: 38769391
    [Abstract] [Full Text] [Related]

  • 2. Feasibility of ultrasound radiomics based models for classification of liver fibrosis due to Schistosoma japonicum infection.
    Guo Z, Zhao M, Liu Z, Zheng J, Gong Y, Huang L, Xue J, Zhou X, Li S.
    PLoS Negl Trop Dis; 2024 Jun 20; 18(6):e0012235. PubMed ID: 38870200
    [Abstract] [Full Text] [Related]

  • 3. Clinical diagnosis of Schistosoma japonicum infection complicating infective endocarditis and liver cirrhosis.
    Yanagisawa S, Yuasa T, Tanaka T.
    Intern Med; 2010 Jun 20; 49(11):1001-5. PubMed ID: 20519816
    [Abstract] [Full Text] [Related]

  • 4. Circulating miRNAs as footprints for liver fibrosis grading in schistosomiasis.
    Cai P, Mu Y, Olveda RM, Ross AG, Olveda DU, McManus DP.
    EBioMedicine; 2018 Nov 20; 37():334-343. PubMed ID: 30482723
    [Abstract] [Full Text] [Related]

  • 5. An IL-13 promoter polymorphism associated with liver fibrosis in patients with Schistosoma japonicum.
    Long X, Chen Q, Zhao J, Rafaels N, Mathias P, Liang H, Potee J, Campbell M, Zhang B, Gao L, Georas SN, Vercelli D, Beaty TH, Ruczinski I, Mathias R, Barnes KC, Chen X.
    PLoS One; 2015 Nov 20; 10(8):e0135360. PubMed ID: 26258681
    [Abstract] [Full Text] [Related]

  • 6. Serum proteomic profiling in patients with advanced Schistosoma japonicum-induced hepatic fibrosis.
    Huang J, Yin X, Zhang L, Yao M, Wei D, Wu Y.
    Parasit Vectors; 2021 May 01; 14(1):232. PubMed ID: 33933138
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of granuloma formation and liver fibrosis in murine schistosomiasis mekongi: a morphological comparison between Schistosoma mekongi and S. japonicum infection.
    Shimada M, Kirinoki M, Shimizu K, Kato-Hayashi N, Chigusa Y, Kitikoon V, Pongsasakulchoti P, Matsuda H.
    Parasitology; 2010 Oct 01; 137(12):1781-9. PubMed ID: 20561395
    [Abstract] [Full Text] [Related]

  • 8. A novel proteomic-based model for predicting colorectal cancer with Schistosoma japonicum co-infection by integrated bioinformatics analysis and machine learning.
    Li S, Sun X, Li T, Shi Y, Xu B, Deng Y, Wang S.
    BMC Med Genomics; 2023 Oct 30; 16(1):269. PubMed ID: 37904220
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A simple noninvasive index to predict significant liver fibrosis in patients with advanced schistosomiasis japonica.
    Wu YM, Xu N, Hu JY, Xu XF, Wu WX, Gao SX, Zhu WJ, Wu WL, Shen XZ, Wang JY, Wu SD.
    Parasitol Int; 2013 Jun 30; 62(3):283-8. PubMed ID: 23466574
    [Abstract] [Full Text] [Related]

  • 11. Improvement of Mitochondrial Activity and Fibrosis by Resveratrol Treatment in Mice with Schistosoma japonicum Infection.
    Chen TT, Peng S, Wang Y, Hu Y, Shen Y, Xu Y, Yin J, Liu C, Cao J.
    Biomolecules; 2019 Oct 25; 9(11):. PubMed ID: 31717714
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Association between serum lipid profile and liver fibrosis in patients infected with Schistosoma japonicum.
    Liu Y, Zhang P, Li J, Li H, Zhou C, Zhang Y, Ming Y.
    Parasit Vectors; 2022 Jul 29; 15(1):268. PubMed ID: 35906693
    [Abstract] [Full Text] [Related]

  • 14. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
    Karagoz E, Ulcay A, Tanoglu A, Kara M, Turhan V, Erdem H, Oncul O, Gorenek L.
    Eur J Gastroenterol Hepatol; 2014 Dec 29; 26(12):1320-4. PubMed ID: 25210777
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characteristics of peripheral lymphocyte subsets in patients with different stages of schistosomiasis japonica.
    Zhou Z, Li J, Jiang J, Luo Y, Yingzi M.
    Parasite Immunol; 2023 Oct 29; 45(10):e13006. PubMed ID: 37551055
    [Abstract] [Full Text] [Related]

  • 19. Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum.
    Chen H, He YW, Liu WQ, Zhang JH.
    World J Gastroenterol; 2008 May 14; 14(18):2905-11. PubMed ID: 18473419
    [Abstract] [Full Text] [Related]

  • 20. Exogenous bone morphogenetic protein-7 reduces hepatic fibrosis in Schistosoma japonicum-infected mice via transforming growth factor-β/Smad signaling.
    Chen BL, Peng J, Li QF, Yang M, Wang Y, Chen W.
    World J Gastroenterol; 2013 Mar 07; 19(9):1405-15. PubMed ID: 23539268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.